Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (388)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Schilsky, RichardPerson Why?
Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.Academic Article Why?
Novel molecular targeted therapies for refractory thyroid cancer.Academic Article Why?
Predicting response of molecular targeted therapies: a still possible challenge?Academic Article Why?
The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies.Academic Article Why?
Molecular Targeted TherapyConcept Why?
Salgia, RaviPerson Why?
Luke, JasonPerson Why?
Piunti, AndreaPerson Why?
Garassino, Marina ChiaraPerson Why?
A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.Academic Article Why?
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis.Academic Article Why?
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.Academic Article Why?
A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.Academic Article Why?
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.Academic Article Why?
Per Page    Page  of 26last Nextnext
Prev
Search Criteria
  • Molecular Targeted Therapies
Filter by Type